This upregulation suppresses the extracellular signal-regulated kinase (ERK1/2) and p38MAPK signaling pathways, leading to reduced blood glucose and serum insulin levels in T2DM mice (Chen X. et al., 2022). The gene discussed is INS; the disease is type 2 diabetes mellitus.